Internet registration and listing
This article was originally published in The Gray Sheet
Executive SummaryEvaluation of the Phase II pilot of the Center for Devices and Radiological Health Internet interface for meeting establishment registration and device listing requirements is posted May 1. Nine device firms participated in testing the R&L pilot (www.fda.gov/cdrh/registration/regpiloteval.html). The center is developing a proposed rule for implementation of electronic R&L. Once the data elements have been finalized, staffers will design the official interface, FDA says
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.